Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniosynostoses | 9 | 2020 | 62 | 0.890 |
Why?
|
| Neurosurgical Procedures | 4 | 2018 | 101 | 0.870 |
Why?
|
| Laser Therapy | 3 | 2019 | 56 | 0.830 |
Why?
|
| Dura Mater | 4 | 2018 | 14 | 0.790 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 62 | 0.780 |
Why?
|
| Infant | 17 | 2020 | 1122 | 0.770 |
Why?
|
| Syringomyelia | 2 | 2021 | 3 | 0.630 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 2 | 2018 | 10 | 0.620 |
Why?
|
| Pituitary Neoplasms | 2 | 2018 | 17 | 0.610 |
Why?
|
| Epilepsy, Generalized | 1 | 2018 | 4 | 0.590 |
Why?
|
| Corpus Callosum | 1 | 2018 | 18 | 0.580 |
Why?
|
| Syncope | 1 | 2018 | 28 | 0.570 |
Why?
|
| Spine | 1 | 2018 | 45 | 0.570 |
Why?
|
| Craniopharyngioma | 1 | 2018 | 8 | 0.570 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2018 | 5 | 0.570 |
Why?
|
| Craniotomy | 8 | 2020 | 46 | 0.560 |
Why?
|
| Subdural Space | 1 | 2017 | 1 | 0.540 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2017 | 3 | 0.540 |
Why?
|
| Child, Preschool | 10 | 2018 | 1354 | 0.540 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 71 | 0.520 |
Why?
|
| Treatment Outcome | 15 | 2021 | 3618 | 0.520 |
Why?
|
| Plagiocephaly, Nonsynostotic | 2 | 2013 | 10 | 0.490 |
Why?
|
| Spinal Fusion | 3 | 2021 | 64 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 399 | 0.460 |
Why?
|
| Reconstructive Surgical Procedures | 8 | 2020 | 202 | 0.460 |
Why?
|
| Humans | 36 | 2021 | 34474 | 0.420 |
Why?
|
| Cervical Vertebrae | 2 | 2015 | 54 | 0.420 |
Why?
|
| Head Protective Devices | 1 | 2013 | 49 | 0.400 |
Why?
|
| Retinal Hemorrhage | 2 | 2012 | 14 | 0.370 |
Why?
|
| Male | 24 | 2021 | 20697 | 0.360 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2011 | 6 | 0.350 |
Why?
|
| Brain Injuries | 2 | 2012 | 94 | 0.350 |
Why?
|
| Child | 8 | 2021 | 2613 | 0.350 |
Why?
|
| Ventriculostomy | 2 | 2010 | 12 | 0.350 |
Why?
|
| Occipital Bone | 2 | 2015 | 18 | 0.340 |
Why?
|
| Accidental Falls | 2 | 2012 | 116 | 0.340 |
Why?
|
| Absorbable Implants | 2 | 2017 | 27 | 0.330 |
Why?
|
| Adolescent | 5 | 2019 | 3799 | 0.330 |
Why?
|
| Rifampin | 1 | 2010 | 8 | 0.330 |
Why?
|
| Staphylococcus epidermidis | 1 | 2010 | 6 | 0.330 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2010 | 9 | 0.320 |
Why?
|
| Minocycline | 1 | 2010 | 12 | 0.320 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 19 | 0.320 |
Why?
|
| Neck Injuries | 1 | 2010 | 14 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2019 | 1386 | 0.310 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 47 | 0.300 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 83 | 0.300 |
Why?
|
| Female | 19 | 2021 | 21490 | 0.300 |
Why?
|
| Retrospective Studies | 12 | 2020 | 3812 | 0.290 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2019 | 7 | 0.280 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 2366 | 0.280 |
Why?
|
| Decompression, Surgical | 2 | 2021 | 57 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 352 | 0.260 |
Why?
|
| Scoliosis | 2 | 2018 | 36 | 0.250 |
Why?
|
| Lumbar Vertebrae | 2 | 2004 | 113 | 0.250 |
Why?
|
| Blood Loss, Surgical | 3 | 2015 | 55 | 0.230 |
Why?
|
| Skull | 3 | 2020 | 49 | 0.220 |
Why?
|
| Infant, Newborn | 2 | 2018 | 730 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2015 | 984 | 0.210 |
Why?
|
| Subdural Effusion | 1 | 2003 | 5 | 0.210 |
Why?
|
| Radiography | 4 | 2015 | 397 | 0.190 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 245 | 0.180 |
Why?
|
| Cerebral Revascularization | 1 | 2002 | 10 | 0.180 |
Why?
|
| Erythrocyte Transfusion | 1 | 2002 | 35 | 0.180 |
Why?
|
| Recurrence | 2 | 2017 | 295 | 0.170 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2021 | 8 | 0.170 |
Why?
|
| Hemispherectomy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Age Factors | 2 | 2013 | 1261 | 0.140 |
Why?
|
| Brain Abscess | 1 | 2018 | 4 | 0.140 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 6 | 0.140 |
Why?
|
| Developing Countries | 1 | 2018 | 60 | 0.140 |
Why?
|
| Neurosurgery | 1 | 2018 | 38 | 0.140 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 57 | 0.140 |
Why?
|
| Mental Recall | 1 | 2018 | 52 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 68 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 116 | 0.130 |
Why?
|
| Tissue Adhesives | 1 | 2017 | 7 | 0.130 |
Why?
|
| Young Adult | 3 | 2019 | 2825 | 0.130 |
Why?
|
| Incidence | 2 | 2018 | 1288 | 0.130 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 33 | 0.130 |
Why?
|
| Perioperative Care | 2 | 2011 | 57 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 2016 | 35 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2017 | 59 | 0.120 |
Why?
|
| Bone Plates | 1 | 2017 | 74 | 0.120 |
Why?
|
| Hippocampus | 1 | 2018 | 225 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 260 | 0.120 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 12 | 0.120 |
Why?
|
| Huntington Disease | 1 | 2016 | 15 | 0.120 |
Why?
|
| Hydrogels | 1 | 2017 | 127 | 0.120 |
Why?
|
| Spinal Curvatures | 1 | 2015 | 1 | 0.120 |
Why?
|
| Muscular Dystrophies | 1 | 2015 | 4 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2015 | 12 | 0.120 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2015 | 3 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 16 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2015 | 17 | 0.120 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 18 | 0.110 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2015 | 30 | 0.110 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 5 | 0.110 |
Why?
|
| Antifibrinolytic Agents | 1 | 2015 | 16 | 0.110 |
Why?
|
| Calcinosis | 1 | 2015 | 150 | 0.110 |
Why?
|
| Disease Management | 1 | 2015 | 134 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 4150 | 0.110 |
Why?
|
| Fracture Fixation, Internal | 1 | 2015 | 131 | 0.110 |
Why?
|
| Vein of Galen Malformations | 1 | 2013 | 4 | 0.100 |
Why?
|
| Comorbidity | 1 | 2015 | 596 | 0.100 |
Why?
|
| Cerebral Veins | 1 | 2013 | 12 | 0.100 |
Why?
|
| Disease Progression | 1 | 2015 | 633 | 0.100 |
Why?
|
| Medical Subject Headings | 1 | 2012 | 2 | 0.090 |
Why?
|
| PubMed | 1 | 2012 | 8 | 0.090 |
Why?
|
| Dermoid Cyst | 1 | 2012 | 3 | 0.090 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 4 | 0.090 |
Why?
|
| Information Storage and Retrieval | 1 | 2012 | 28 | 0.090 |
Why?
|
| Frontal Bone | 1 | 2012 | 14 | 0.090 |
Why?
|
| Forensic Pathology | 1 | 2011 | 13 | 0.090 |
Why?
|
| Ophthalmoscopy | 1 | 2011 | 9 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2011 | 87 | 0.090 |
Why?
|
| Surgical Equipment | 2 | 2020 | 10 | 0.080 |
Why?
|
| Frontal Sinus | 1 | 2010 | 2 | 0.080 |
Why?
|
| Mucocele | 1 | 2010 | 2 | 0.080 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2010 | 4 | 0.080 |
Why?
|
| Anesthesia | 1 | 2011 | 72 | 0.080 |
Why?
|
| Cerebral Aqueduct | 1 | 2010 | 3 | 0.080 |
Why?
|
| Hydrocephalus | 1 | 2010 | 12 | 0.080 |
Why?
|
| Neurocysticercosis | 1 | 2010 | 5 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 19 | 0.080 |
Why?
|
| Adult | 6 | 2019 | 10015 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 649 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 81 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2010 | 32 | 0.080 |
Why?
|
| Neurologic Examination | 1 | 2010 | 31 | 0.080 |
Why?
|
| Decision Trees | 1 | 2010 | 31 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2021 | 1910 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2013 | 360 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2010 | 87 | 0.080 |
Why?
|
| Cranial Sutures | 1 | 2009 | 14 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2020 | 849 | 0.070 |
Why?
|
| Blood Transfusion | 3 | 2015 | 76 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 819 | 0.070 |
Why?
|
| Amygdala | 2 | 2019 | 64 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 540 | 0.060 |
Why?
|
| Hematocrit | 3 | 2015 | 23 | 0.060 |
Why?
|
| Aged | 4 | 2019 | 10998 | 0.050 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2003 | 6 | 0.050 |
Why?
|
| Meningomyelocele | 1 | 2003 | 10 | 0.050 |
Why?
|
| Cutaneous Fistula | 1 | 2003 | 4 | 0.050 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 4 | 0.050 |
Why?
|
| Meningitis | 1 | 2003 | 9 | 0.050 |
Why?
|
| Laminectomy | 1 | 2003 | 17 | 0.050 |
Why?
|
| Fistula | 1 | 2003 | 11 | 0.050 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 104 | 0.050 |
Why?
|
| Polyesters | 1 | 2004 | 78 | 0.050 |
Why?
|
| Spinal Diseases | 1 | 2003 | 24 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2004 | 53 | 0.050 |
Why?
|
| Bone Screws | 1 | 2004 | 64 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2003 | 61 | 0.050 |
Why?
|
| Middle Aged | 4 | 2019 | 12703 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 101 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2010 | 2461 | 0.050 |
Why?
|
| Testosterone | 1 | 2003 | 51 | 0.050 |
Why?
|
| Adenoma | 1 | 2003 | 36 | 0.050 |
Why?
|
| Anemia | 1 | 2003 | 58 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 385 | 0.050 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2002 | 9 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2002 | 31 | 0.050 |
Why?
|
| Postoperative Hemorrhage | 1 | 2002 | 41 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 2352 | 0.040 |
Why?
|
| Neuroendoscopy | 1 | 2020 | 4 | 0.040 |
Why?
|
| Executive Function | 1 | 2020 | 60 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 138 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 265 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2019 | 8 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 101 | 0.040 |
Why?
|
| Seizures | 1 | 2019 | 67 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2017 | 3 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 24 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 63 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 76 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 58 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 56 | 0.030 |
Why?
|
| Atlanto-Axial Joint | 1 | 2015 | 4 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 70 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2016 | 75 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 265 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 214 | 0.030 |
Why?
|
| Premedication | 1 | 2015 | 17 | 0.030 |
Why?
|
| Safety | 1 | 2015 | 82 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 245 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 86 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 2012 | 3 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2012 | 7 | 0.020 |
Why?
|
| Hematoma, Subdural | 1 | 2012 | 12 | 0.020 |
Why?
|
| Bone Matrix | 1 | 2012 | 3 | 0.020 |
Why?
|
| Dissection | 1 | 2012 | 18 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2012 | 13 | 0.020 |
Why?
|
| Curettage | 1 | 2012 | 10 | 0.020 |
Why?
|
| Superior Sagittal Sinus | 1 | 2012 | 6 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 35 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2012 | 12 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2011 | 11 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 2011 | 18 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 2011 | 20 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 45 | 0.020 |
Why?
|
| Forehead | 1 | 2010 | 13 | 0.020 |
Why?
|
| Anticestodal Agents | 1 | 2010 | 3 | 0.020 |
Why?
|
| Taenia solium | 1 | 2010 | 3 | 0.020 |
Why?
|
| Albendazole | 1 | 2010 | 4 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 137 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 464 | 0.020 |
Why?
|
| Cephalometry | 1 | 2010 | 19 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2010 | 16 | 0.020 |
Why?
|
| Headache | 1 | 2010 | 78 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 276 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 102 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 53 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2010 | 127 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 192 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 335 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4267 | 0.020 |
Why?
|
| Hypogonadism | 1 | 2003 | 4 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 2003 | 7 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 707 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 8544 | 0.010 |
Why?
|